In conclusion, the researcher had proved that the tBregs could transform nonregulatory CD4+ T cells (non-Tregs) to active Tregs through secreting the TGF-β, which in turn inhibited T cells proliferation and increased tumor metastasis [53, 54]. The gene discussed is TGFB1; the disease is neoplasm.